ISI (Twist Bioscience) was listed on the Nasdaq stock exchange, and Barclays raised its price target on the company on July 9, 2026.
4 reports, 2 independent
Updated Oct 23
Gone quiet
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
ISI (Twist Bioscience) was listed on the Nasdaq stock exchange, and Barclays raised its price target on the company on July 9, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Jefferies initiated coverage and TD Cowen lifted price objective for Twist Bioscience.1 source
Barclays raised price targets on ISI (Twist Bioscience) after its listing on Nasdaq.1 source
Keep exploring
The entities involved
- ISI
-
Twist Bioscience
Biotechnology company
Nothing else this week.
-
Barclays
British bank
Related events
- Barclays influenced price targets for Nasdaq. Analyst ratings affect market perception of Nasdaq.
- Multiple major banks, including Citigroup, UBS, Bank of America, and Barclays, have issued updated price targets and ratings.
- ISI downgraded Hewlett Packard Enterprise stock due to stretched valuation, and TipRanks provided stock analysis on October 12, 2026.
- Goldman Sachs, TD Cowen, and Barclays cited valuation and growth concerns, leading to downgrades on July 25, 2026.
- On July 22, 2026, multiple financial institutions issued rating and price target updates for Super Micro Computer, Inc., amid robust AI server demand.